GLP-1 drugs: what Rhode Island Medicaid paid

Q: Does a paid prescription mean Rhode Island Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Rhode Island Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Rhode Island Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Rhode Island Medicaid’s payment record shows

In 2026Q1, the product Rhode Island Medicaid paid for most often was Ozempic®, at 5,147 prescriptions¹⁹ of the 11,873 to 12,071^{1,7,13,19,25,43} across all 8 products, or 43 percent of the published count.

Rhode Island Medicaid itself reimbursed at least $12,834,830 for these products in the quarter, about $1,083 per prescription. Pharmacies were paid $12,850,820 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,302.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Rhode Island Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Rhode Island Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Rhode Island Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Rhode Island Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both2,136 managed care, 11 direct	at least 2,147¹	18%	$2,262,002	$2,262,002	$1,054
tirzepatideMounjaro®	Both2,320 managed care, 76 direct	at least 2,396⁷	20%	$2,652,779	$2,654,851	$1,107
semaglutideWegovy®	Both1,693 managed care, 118 direct	at least 1,811¹³	15%	$2,358,146	$2,366,648	$1,302
semaglutideOzempic®	Both5,037 managed care, 110 direct	5,147¹⁹	43%	$5,217,839	$5,223,255	$1,014
semaglutideRybelsus®	Managed care	at least 308²⁵	3%	$311,287	$311,287	$1,011
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Managed care	at least 42⁴³	<1%	$32,778	$32,778	$780

Rhode Island Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 46.0 to 46.8 prescriptions per thousand people enrolled in Rhode Island Medicaid, on an average of 257,860 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 10 of the 168 product-quarters it holds a row for here, which is 6 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Rhode Island Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Rhode Island Medicaid paid for each product, quarter by quarter

Prescriptions Rhode Island Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 11 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$11,305 paid	at least 256 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$260,865 paid	at least 350 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$348,167 paid	at least 437 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$420,809 paid	at least 572 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$552,317 paid	at least 812 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$838,152 paid	at least 1,304 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$1,375,534 paid	at least 1,636 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$1,727,533 paid	at least 1,884 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$1,990,338 paid	at least 2,147 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$2,262,002 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 12 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$11,460 paid	at least 85 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$81,436 paid	at least 123 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$114,903 paid	at least 154 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$139,678 paid	242 paid prescriptions in the quarter (2023Q3)¹⁰Count$245,247 paid	at least 355 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$361,529 paid	at least 714 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$777,432 paid	at least 828 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$900,192 paid	at least 1,023 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$1,095,664 paid	at least 1,107 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$1,186,851 paid	at least 1,279 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$1,408,594 paid	at least 1,637 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$1,725,978 paid	at least 1,920 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$2,041,394 paid	at least 2,115 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$2,258,176 paid	at least 2,396 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$2,652,779 paid
semaglutideWegovy®range 1,787 to 1,897	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld6 of 6 product codes withheld	at least 74 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$95,836 paid	at least 91 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹⁷At least$117,719 paid	at least 78 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$101,281 paid	at least 86 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$111,608 paid	at least 726 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$952,065 paid	at least 899 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁶At least$1,168,542 paid	at least 770 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$935,362 paid	at least 700 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁶At least$885,877 paid	at least 764 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld¹⁵At least$1,004,533 paid	at least 1,051 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$1,330,551 paid	at least 1,240 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$1,510,160 paid	at least 1,296 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$1,565,953 paid	at least 1,516 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$1,923,129 paid	at least 1,699 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$2,223,025 paid	1,787 paid prescriptions in the quarter (2025Q3)¹⁴Count$2,336,644 paid	1,897 paid prescriptions in the quarter (2025Q4)¹⁴Count$2,488,418 paid	at least 1,811 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$2,358,146 paid
semaglutideOzempic®range 4,354 to 5,698, down 140 on the quarter before	at least 302 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$248,456 paid	at least 264 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$224,539 paid	at least 483 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$405,192 paid	at least 599 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$496,536 paid	at least 795 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$679,671 paid	at least 1,069 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$917,896 paid	at least 1,406 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,211,939 paid	at least 1,349 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$1,157,008 paid	at least 1,738 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$1,529,011 paid	at least 2,164 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$1,923,470 paid	at least 2,400 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$2,170,372 paid	at least 2,131 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$1,937,098 paid	at least 3,184 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$3,010,925 paid	4,354 paid prescriptions in the quarter (2024Q2)²¹Count$4,124,515 paid	at least 5,070 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$4,844,598 paid	4,971 paid prescriptions in the quarter (2024Q4)²¹Count$4,779,293 paid	5,168 paid prescriptions in the quarter (2025Q1)²⁰Count$5,067,802 paid	5,698 paid prescriptions in the quarter (2025Q2)²⁰Count$5,532,817 paid	5,336 paid prescriptions in the quarter (2025Q3)²⁰Count$5,201,975 paid	5,287 paid prescriptions in the quarter (2025Q4)²⁰Count$5,187,561 paid	5,147 paid prescriptions in the quarter (2026Q1)¹⁹Count$5,217,839 paid
semaglutideRybelsus®range 71 to 232	71 paid prescriptions in the quarter (2021Q1)³⁰Count$58,859 paid	86 paid prescriptions in the quarter (2021Q2)³⁰Count$68,016 paid	180 paid prescriptions in the quarter (2021Q3)³⁰Count$145,750 paid	232 paid prescriptions in the quarter (2021Q4)³⁰Count$188,980 paid	at least 248 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$208,363 paid	at least 265 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$227,643 paid	at least 334 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$292,947 paid	at least 385 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$327,433 paid	at least 456 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$404,699 paid	at least 467 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$422,908 paid	at least 468 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$429,837 paid	at least 413 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$382,448 paid	at least 437 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$417,810 paid	at least 453 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$428,690 paid	at least 443 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$419,696 paid	at least 377 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$360,299 paid	at least 348 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$344,468 paid	at least 334 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$324,023 paid	at least 307 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$296,220 paid	at least 302 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$291,652 paid	at least 308 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$311,287 paid
liraglutideSaxenda®range 12 to 319	34 paid prescriptions in the quarter (2021Q1)³⁶Count$43,921 paid	35 paid prescriptions in the quarter (2021Q2)³⁶Count$46,503 paid	89 paid prescriptions in the quarter (2021Q3)³⁶Count$104,879 paid	at least 99 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁶At least$120,639 paid	at least 115 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld³⁵At least$142,640 paid	at least 114 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld³⁵At least$137,725 paid	at least 257 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld³⁵At least$308,990 paid	at least 363 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld³⁵At least$444,655 paid	319 paid prescriptions in the quarter (2023Q1)³⁴Count$399,122 paid	at least 198 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld³⁴At least$247,899 paid	98 paid prescriptions in the quarter (2023Q3)³⁴Count$108,708 paid	45 paid prescriptions in the quarter (2023Q4)³⁴Count$55,793 paid	12 paid prescriptions in the quarter (2024Q1)³³Count$15,067 paid	30 paid prescriptions in the quarter (2024Q2)³³Count$36,765 paid	50 paid prescriptions in the quarter (2024Q3)³³Count$58,789 paid	42 paid prescriptions in the quarter (2024Q4)³³Count$52,560 paid	51 paid prescriptions in the quarter (2025Q1)³²Count$56,659 paid	56 paid prescriptions in the quarter (2025Q2)³²Count$66,654 paid	49 paid prescriptions in the quarter (2025Q3)³²Count$57,056 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®	at least 346 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld⁴²At least$277,953 paid	at least 241 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld⁴²At least$201,557 paid	at least 354 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld⁴²At least$295,054 paid	at least 333 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld⁴²At least$270,334 paid	at least 348 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld⁴¹At least$287,656 paid	309 paid prescriptions in the quarter (2022Q2)⁴¹Count$259,871 paid	at least 197 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld⁴¹At least$171,649 paid	at least 231 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld⁴¹At least$206,575 paid	at least 211 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$176,540 paid	at least 205 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$180,504 paid	at least 207 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$183,688 paid	at least 167 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$149,542 paid	at least 139 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$85,546 paid	at least 92 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$62,561 paid	at least 19 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$10,189 paid	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³⁹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld1 of 1 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 42 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$26,810 paid	at least 49 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$31,250 paid	at least 45 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$23,361 paid	at least 49 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$23,674 paid	at least 32 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$22,018 paid	at least 71 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$53,995 paid	at least 42 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$32,778 paid

What this page cannot tell you

Whether Rhode Island Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Rhode Island in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, RI
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "461"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, RI
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "389"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, RI
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "140"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, RI
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, RI
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "product_name": "product_name like ZEPBOUND%, state RI, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, RI
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "product_name": "product_name like ZEPBOUND%, state RI, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, RI
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "510"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, RI
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "435"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, RI
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "268"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, RI
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "94"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, RI
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "50"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, RI
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "product_name": "product_name like MOUNJARO%, state RI, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, RI
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "594"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, RI
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "636"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, RI
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "468"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, RI
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "481"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, RI
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "68"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, RI
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, RI
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "1928"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, RI
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1968"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, RI
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2296"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, RI
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1094"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, RI
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "849"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, RI
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "377"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, RI
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "148"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, RI
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "190"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, RI
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "219"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, RI
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "240"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, RI
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "196"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, RI
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "90"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, RI
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, RI
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "56"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, RI
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "50"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, RI
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "319"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, RI
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "363"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, RI
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "99"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, RI
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, RI
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, RI
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "107"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, RI
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "157"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, RI
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "196"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, RI
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "189"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, RI
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state RI, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "RI", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, RI
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state RI, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "44"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, RI
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state RI, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "25"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, RI
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state RI, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "product_name": "product_name like LIRAGLUTID%, state RI, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, RI
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state RI, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "product_name": "product_name like LIRAGLUTID%, state RI, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, RI
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state RI, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "RI", "product_name": "product_name like LIRAGLUTID%, state RI, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Rhode Island Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.